BR9509276A - Processes for producing an enteric bacterium to test a potential antimicrobial agent to detect antibodies of a host to enteric bacteria and enteric bacteria in an animal or biological sample of it to produce antibacterial antibodies and to stimulate an immuno-response in an animal enteric bacteria having increased vaccine and kit antigenic properties diagnostic test to detect a host of antibodies to enteric bacteria or to detect enteric bacteria - Google Patents

Processes for producing an enteric bacterium to test a potential antimicrobial agent to detect antibodies of a host to enteric bacteria and enteric bacteria in an animal or biological sample of it to produce antibacterial antibodies and to stimulate an immuno-response in an animal enteric bacteria having increased vaccine and kit antigenic properties diagnostic test to detect a host of antibodies to enteric bacteria or to detect enteric bacteria

Info

Publication number
BR9509276A
BR9509276A BR9509276A BR9509276A BR9509276A BR 9509276 A BR9509276 A BR 9509276A BR 9509276 A BR9509276 A BR 9509276A BR 9509276 A BR9509276 A BR 9509276A BR 9509276 A BR9509276 A BR 9509276A
Authority
BR
Brazil
Prior art keywords
enteric bacteria
detect
antibodies
enteric
host
Prior art date
Application number
BR9509276A
Other languages
Portuguese (pt)
Inventor
John L Pace
Richard Ian Walker
Steven M Frey
Original Assignee
Antex Biolog Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/538,545 external-priority patent/US5679564A/en
Application filed by Antex Biolog Inc filed Critical Antex Biolog Inc
Publication of BR9509276A publication Critical patent/BR9509276A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/107—Vibrio
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • C12Q1/045—Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18—Testing for antimicrobial activity of a material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
BR9509276A 1994-10-05 1995-10-04 Processes for producing an enteric bacterium to test a potential antimicrobial agent to detect antibodies of a host to enteric bacteria and enteric bacteria in an animal or biological sample of it to produce antibacterial antibodies and to stimulate an immuno-response in an animal enteric bacteria having increased vaccine and kit antigenic properties diagnostic test to detect a host of antibodies to enteric bacteria or to detect enteric bacteria BR9509276A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US31840994A 1994-10-05 1994-10-05
US08/538,545 US5679564A (en) 1994-10-05 1995-10-03 Methods for producing enhanced antigenic campylobacter bacteria and vaccines
US08/538,543 US5681736A (en) 1994-10-05 1995-10-03 Methods for producing enhanced antigenic shigella bacteria and vaccines comprising same
PCT/US1995/013196 WO1996011258A1 (en) 1994-10-05 1995-10-04 Methods for producing enhanced antigenic enteric bacteria and vaccines comprising same

Publications (1)

Publication Number Publication Date
BR9509276A true BR9509276A (en) 1997-11-18

Family

ID=27405987

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9509276A BR9509276A (en) 1994-10-05 1995-10-04 Processes for producing an enteric bacterium to test a potential antimicrobial agent to detect antibodies of a host to enteric bacteria and enteric bacteria in an animal or biological sample of it to produce antibacterial antibodies and to stimulate an immuno-response in an animal enteric bacteria having increased vaccine and kit antigenic properties diagnostic test to detect a host of antibodies to enteric bacteria or to detect enteric bacteria

Country Status (16)

Country Link
EP (1) EP0804542A4 (en)
JP (1) JP3394047B2 (en)
CN (1) CN1168693A (en)
AU (1) AU704283B2 (en)
BR (1) BR9509276A (en)
CA (1) CA2202027A1 (en)
CZ (1) CZ104397A3 (en)
FI (1) FI971403A (en)
HU (1) HUT77876A (en)
IL (1) IL115521A0 (en)
MX (1) MX9702431A (en)
NO (1) NO971519L (en)
NZ (1) NZ295907A (en)
PL (1) PL182700B1 (en)
SG (2) SG73509A1 (en)
WO (1) WO1996011258A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0792347B1 (en) * 1994-10-05 2005-11-23 Antex Biologics, Inc. Methods for producing enhanced antigenic helicobacter sp. and vaccines comprising same
EP2267006A1 (en) * 2003-05-30 2010-12-29 Intercell AG Enterococcus antigens
US20100074846A1 (en) * 2006-03-17 2010-03-25 Ellis John A Campylobacter Vaccines and Methods of use
EP2161035B1 (en) * 2007-05-28 2019-08-21 Daiichi Sankyo Company, Limited Bordetella parapertussis-containing whole-cell vaccine composition
CN107513553B (en) * 2017-09-18 2021-05-18 江南大学 Method for screening lactobacillus with antagonistic campylobacter jejuni infection function
CN109633151B (en) * 2018-12-26 2022-03-11 西北农林科技大学 Salmonella enteritidis detection method, test strip and application

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU657168B2 (en) * 1991-09-18 1995-03-02 Amgen, Inc. Hepatitis B vaccine with bile salt adjuvant

Also Published As

Publication number Publication date
PL319580A1 (en) 1997-08-18
CN1168693A (en) 1997-12-24
NZ295907A (en) 1999-04-29
FI971403A0 (en) 1997-04-04
PL182700B1 (en) 2002-02-28
CZ104397A3 (en) 1998-06-17
EP0804542A1 (en) 1997-11-05
NO971519D0 (en) 1997-04-03
WO1996011258A1 (en) 1996-04-18
EP0804542A4 (en) 1998-10-28
HUT77876A (en) 1998-09-28
IL115521A0 (en) 1996-06-18
SG73509A1 (en) 2000-06-20
AU704283B2 (en) 1999-04-15
JP3394047B2 (en) 2003-04-07
MX9702431A (en) 1998-05-31
AU3956195A (en) 1996-05-02
NO971519L (en) 1997-05-27
JPH10507347A (en) 1998-07-21
SG73510A1 (en) 2000-06-20
CA2202027A1 (en) 1996-04-18
FI971403A (en) 1997-06-04

Similar Documents

Publication Publication Date Title
BR0016066A (en) Compounds and methods for treatment and diagnosis of chlamydial infection
DE68923932D1 (en) Skin test and test kit for AIDS.
EP2192128A3 (en) Compounds and methods for treatment and diagnosis of chlamydial infection
NO20030252L (en) Compounds and Methods for the Treatment and Diagnosis of Chlamydia Infection
BR9916020A (en) Compounds and methods for the treatment and diagnosis of chlamydia infection
DE69130986D1 (en) Rotors for analysis and methods for the analysis of biological fluids
DE69531743D1 (en) SYSTEM AND METHOD FOR DIAGNOSIS OF DISEASES IN LIVING TISSUE
WO1998042740A3 (en) Compounds and methods for the diagnosis and treatment of ehrlichia infection
DE69121290T2 (en) Method for the determination of antibodies against Chlamydia Trachomatis and diagnostic preparation for Chlamydia Trachomatis infection
BR9710173A (en) Process of preparation of dna usable in gene therapy use of a plasma dna for the preparation of a pharmaceutical composition for the therapeutic treatment or diagnosis of the human or animal body process of preparation of this pharmaceutical composition and composition comprising a bacterial dna
BR9509276A (en) Processes for producing an enteric bacterium to test a potential antimicrobial agent to detect antibodies of a host to enteric bacteria and enteric bacteria in an animal or biological sample of it to produce antibacterial antibodies and to stimulate an immuno-response in an animal enteric bacteria having increased vaccine and kit antigenic properties diagnostic test to detect a host of antibodies to enteric bacteria or to detect enteric bacteria
WO2000000615A3 (en) Compounds and methods for the diagnosis and treatment of ehrlichia infection
Derakhshanfar et al. A study on avian cellulitis in broiler chickens.
DE59703508D1 (en) DEVICE FOR EXAMINING BIOLOGICAL AND MEDICAL SAMPLES
Gadberry et al. Pasteurella pneumotropica isolated from bone and joint infections
BR9509275A (en) Processes for producing helicobacter bacteria having increased antigenic properties testing a potential antimicrobial agent to detect antibodies of a host to helicobacter bacteria and helicobacter bacteria in an animal or biological sample of it to produce antibacterial antibodies and to stimulate and stimulate an immunoresponse in an animal helicobacter bacterium vaccine and kit of diagnostic test to detect a host of antibodies to helicobacter bacteria or to detect helicobacter bacteria
McFarland et al. Profiles of toxin production by thermophilic Campylobacter of animal origin
Hussaini et al. Studies on Escherichia coli vaccines: estimation of endotoxins in veterinary vaccines
Tauxe New approaches to surveillance and control of emerging foodborne infectious diseases.
Young A stain for demonstrating Helicobacter pylori in gastric biopsies
Champlin et al. Low propensity for poultry isolates of Pasteurella multocida to acquire adaptive resistance to oxytetracycline
PT809653E (en) HELICOBACTER PYLORI ANIGENIUM
DE3765916D1 (en) PROBE FOR INTRODUCTION IN THE DIGESTIVE OR ELIMINATING WAY OF THE HUMAN OR ANIMAL BODY, IN PARTICULAR LITHOTRIPTOR PROBE.
RU95110283A (en) Method of bacterium identification
RU2001113031A (en) A method for evaluating the virulent properties of S-forms of brucella

Legal Events

Date Code Title Description
FB36 Technical and formal requirements: requirement - article 36 of industrial property law
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: DE ACORDO COM O ART. 37, INDEFIRO O PRESENTE PEDIDO, TENDO POR BASE O ARTIGO 10 INCISO IX E ARTIGO 25 DA LPI 9.279 DE 14/05/96 E ART. 229-A DA LEI 10.196 DE 14/02/01.